January 26, 2022
1 minute read
Recent data revealed that 20% of adults are prescribed obesogenic drugs, with beta-blockers and diabetes drugs being the most commonly prescribed. A report on the data made headlines in endocrinology last week.
In another landmark paper, new data showed that children with COVID-19 were more likely to develop diabetes than children without COVID-19 and those with non-COVID-19 acute respiratory infection.
Read these and many more endocrinology stories below:
20% of adults use drugs that cause weight gain
One in five adults in the 2017-2018 National Health and Nutrition Survey said they had prescribed obesogenic drugs, according to results published in Obesity. Read more.
Children with COVID-19 are more likely to be newly diagnosed with diabetes
According to the results of a study published in Morbidity and Mortality Weekly Report. Read more.
Time in target glucose range may decrease after COVID-19 vaccine in type 1 diabetes
The first dose of a COVID-19 vaccine may lead to a decrease in interstitial glucose time in the range for adults with type 1 diabetes, according to study results published in diabetes medicine. Read more.
HbA1c remains suboptimal for most people with type 1 diabetes
In an analysis of HbA1c data from 22 countries, most children and adults with type 1 diabetes do not have HbA1cs below 7.5%, although glycemic control varies considerably by age and country, according to the study data. Read more.
“Variable impacts” on calcium absorption with a prebiotic supplement after gastric bypass surgery
Postmenopausal women who received a daily prebiotic supplement years after gastric bypass saw no change in calcium absorption compared to women who received a placebo, although some differential responses were seen in the prebiotic group . Read more.